Diabetologia
SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System
Cohort study of 2,397 peopleInterventions
More on SGLT2 inhibitors
Clinical Pharmacology and Therapeutics4 Oct 2026
SGLT2 inhibitors raise genital but not urinary infection risk
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes, Obesity & Metabolism8 Oct 2026
Diabetes drug class linked to slightly less frailty progression
The American Journal of Cardiology8 Oct 2026
Drug class linked to fewer deaths or complications in kidney disease
